AGIO
Agios Pharmaceuticals Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||||
| Capital Expenditures | 4.3M | 1.7M | 999,000 | 4.9M | 5.7M | 14.1M | 12.0M | 7.0M | 4.6M | 9.9M | 20.2M | 1.3M | 1.5M | 1.9M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||||
| Free Cash Flow | -377.3M | -391.5M | -297.1M | -314.4M | -413.1M | -304.9M | -382.6M | -311.4M | -289.9M | 28.6M | -97.1M | -57.7M | -51.0M | -17.1M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |